Sore Throat News and Research RSS Feed - Sore Throat News and Research

Vertex receives positive opinion from European CHMP for approval of KALYDECO for cystic fibrosis

Vertex receives positive opinion from European CHMP for approval of KALYDECO for cystic fibrosis

Vertex Pharmaceuticals Incorporated today announced that the European Committee for Medicinal Products for Human Use has issued a positive opinion recommending the approval of KALYDECO (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have one of eight non-G551D gating mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. [More]

Patients kept in the dark on costs of tests, treatments

The CT Mirror examines the difficulties patients face when trying to comparison shop or simply figure out how much they might have to spend on medical treatments. [More]
Summer offers ideal opportunity to get tonsil removal

Summer offers ideal opportunity to get tonsil removal

Pool pass, sports camp, visiting relatives and getting tonsils removed are all normal activities for children during the summer months. [More]
Verizon advances patient care with new mobile health product

Verizon advances patient care with new mobile health product

Verizon today (June 25) announced the immediate availability of Verizon Virtual Visits, which provides an easy, convenient and cost-effective way for patients to be seen remotely by a clinician for a cold, flu, sore throat or other simple, acute conditions, via video on their smartphone, tablet or computer. [More]
Culture-based tests can help in accurate diagnosis of sore throats

Culture-based tests can help in accurate diagnosis of sore throats

Clinical guidelines conflict on testing teens and adults whose symptoms point to a possible strep throat. [More]
TEVA presents results from real-life, observational study of QVAR at ATS 2014 International Conference

TEVA presents results from real-life, observational study of QVAR at ATS 2014 International Conference

Teva Pharmaceutical Industries Ltd., (NYSE: TEVA) today announced that results from a real-life, retrospective, observational study of QVAR- will be presented at the American Thoracic Society (ATS) 2014 International Conference in San Diego on May 18, 2014. [More]
Data from phase III trials supports safety, efficacy of linagliptin in treating T2D in African-American adults

Data from phase III trials supports safety, efficacy of linagliptin in treating T2D in African-American adults

Data from a retrospective pooled analysis of eight phase III trials (two 18-week and six 24-week) of linagliptin 5 mg once-daily, showed reductions from baseline A1c at 18 (eight trials) and 24 (six trials) weeks compared to placebo in African-American adults with type 2 diabetes (T2D), [More]
Virtual doctors visits await regulation, grow in popularity

Virtual doctors visits await regulation, grow in popularity

And recommendations on digital privacy protections for electronic health records could come as early as June. [More]
First Edition: May 9, 2014

First Edition: May 9, 2014

Today's headlines include highlights from the first Senate confirmation hearing for Sylvia Mathews Burwell, President Barack Obama's pick for Health and Human Services Secretary. [More]
Pfizer reports positive results from two tofacitinib Phase 3 trials for moderate-to-severe plaque psoriasis

Pfizer reports positive results from two tofacitinib Phase 3 trials for moderate-to-severe plaque psoriasis

Pfizer Inc. announced today top-line results from two pivotal Phase 3 trials from the Oral treatment Psoriasis Trials (OPT) Program, OPT Pivotal #1 (A3921078) and OPT Pivotal #2 (A3921079), evaluating the efficacy and safety of tofacitinib, an oral Janus kinase (JAK) inhibitor, the first in a new class of medicines being investigated for the treatment of moderate-to-severe plaque psoriasis. [More]
People urged to undergo oral cancer screenings as part of Oral Cancer Awareness Month

People urged to undergo oral cancer screenings as part of Oral Cancer Awareness Month

Oral and oropharyngeal cancer (cancer of the mouth and upper throat) collectively kill nearly one person every hour of every day of the year. [More]
Study shows only 23% of seasonal and pandemic flu caused symptoms

Study shows only 23% of seasonal and pandemic flu caused symptoms

Around 1 in 5 of the population were infected in both recent outbreaks of seasonal flu and the 2009 H1N1 influenza pandemic, but just 23% of these infections caused symptoms, and only 17% of people were ill enough to consult their doctor. [More]
FDA approves KALYDECO for people with cystic fibrosis

FDA approves KALYDECO for people with cystic fibrosis

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) for KALYDECOTM (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have one of eight additional mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. KALYDECO was first approved in January 2012 for people with CF ages 6 and older who have at least one copy of the G551D mutation. [More]
FDA approves sNDA to include radiographic data updating label of Pfizer XELJANZ for treatment of RA

FDA approves sNDA to include radiographic data updating label of Pfizer XELJANZ for treatment of RA

Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) to update the current label of XELJANZ® (tofacitinib citrate) 5 mg tablets to include radiographic data from two Phase 3 studies, ORAL Scan (A3921044) and ORAL Start. [More]
URTI risk factor for chronic, recurrent otitis media

URTI risk factor for chronic, recurrent otitis media

Results from a meta-analysis indicate that upper respiratory tract infection increases the odds of chronic or recurrent otitis media over sixfold. [More]
Duration of common pediatric respiratory infections estimated

Duration of common pediatric respiratory infections estimated

An international research team has systematically reviewed the literature to formulate up-to-date estimates of the duration of common childhood respiratory tract infections. [More]
Reflux disease diagnosis: an interview with Professor Peter Dettmar, Managing Director of RD Biomed Limited

Reflux disease diagnosis: an interview with Professor Peter Dettmar, Managing Director of RD Biomed Limited

Generally speaking, reflux has been a major chronic issue for probably the last 40 or 50 years. When you look at the global population, depending on which country we're talking about, around 20% to 40% of individuals have reflux disease within their populations. [More]
College students not only bring dirty socks but also mononucleosis to home

College students not only bring dirty socks but also mononucleosis to home

One of the hallmarks of heading home for winter break is the enormous amounts of laundry college students bring as a welcome home present for Mom and Dad. But the dirty socks might not be the only unwelcome guest they transport home. They might also bring mononucleosis, better known as mono. [More]
In states not expanding Medicaid, hospitals face a squeeze as federal funds dry up

In states not expanding Medicaid, hospitals face a squeeze as federal funds dry up

The New York Times examines the dilemma for some safety-net hospitals that will not see a drop in the uninsured but will lose federal money that used to help pay for those patients. [More]
First Edition: November 11, 2013

First Edition: November 11, 2013

Today's headlines include reports about how Republicans are positioning themselves to capitalize on the health law's implementation difficulties in the upcoming election season. [More]